Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ophiopogon japonicus root extract is a botanical extract derived from the roots of *Ophiopogon japonicus*, a perennial plant known as 'Maidong' in traditional Chinese medicine. The extract is rich in steroidal saponins, polysaccharides (fructosans), and homoisoflavonoids. It is primarily utilized in the cosmetic industry for its moisturizing and skin-barrier-enhancing properties, particularly in products designed for eczema-prone or sensitive skin. Pharmacological research has explored its potential anti-inflammatory, antioxidant, anti-diabetic, and cardioprotective effects. One specific commercial form, AD-Resyl, is developed by SILAB for dermatological applications. It has also been investigated for its role in modulating the PI3K-AKT-mTOR/FoxO3a signaling pathway to treat obesity-associated skeletal muscle atrophy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ophiopogon japonicus root extract.